scispace - formally typeset
S

Simona Bottani

Researcher at University of Paris

Publications -  28
Citations -  5901

Simona Bottani is an academic researcher from University of Paris. The author has contributed to research in topics: Computer science & Feature (computer vision). The author has an hindex of 8, co-authored 25 publications receiving 3625 citations. Previous affiliations of Simona Bottani include Allen Institute for Brain Science & French Institute for Research in Computer Science and Automation.

Papers
More filters
Journal ArticleDOI

Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation.

TL;DR: The open-source framework for classification of AD using CNN and T1-weighted MRI is extended and found that more than half of the surveyed papers may have suffered from data leakage and thus reported biased performance.
Journal ArticleDOI

Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data.

TL;DR: A framework for reproducible and objective classification experiments in AD using three publicly available datasets (ADNI, AIBL and OASIS) and a modular set of preprocessing pipelines, feature extraction and classification methods, together with an evaluation framework that provide a baseline for benchmarking the different components are proposed.
Journal ArticleDOI

Clinica: an open source software platform for reproducible clinical neuroscience studies

TL;DR: Clinica is an open-source software platform designed to make clinical neuroscience studies easier and more reproducible, and for researchers to spend less time on data management and processing, and perform reproducible evaluations of their methods.
Journal ArticleDOI

Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review.

TL;DR: A systematic review of studies focusing on the automatic prediction of the progression of mild cognitive impairment to Alzheimer's disease (AD) dementia found that using cognitive, fluorodeoxyglucose-positron emission tomography or potentially electroencephalography and magnetoencephalographic variables significantly improved predictive performance, whereas including other modalities did not show a significant effect.